Online registration for this event is now closed. If you would like to register for this event, please contact Customer Service (800) 892-1400, Option 2.
The FDA has notified Congress that it will soon release the long-awaited draft guidance for the regulation of laboratory-developed tests (LDTs). In its letter to key congressional committees, the Agency outlined its plans for regulating LDTs, and these plans include major changes for labs performing these tests. During this 60-minute webinar, you will hear directly from Dr. Alberto Gutierrez, Director of the FDA’s Office of In Vitro Diagnostic Devices, what the agency’s regulatory intentions are and how they could potentially affect your lab and its ability to perform LDTs. Don’t miss this important program – register today!